Posted by Pfinstegg on May 9, 2003, at 11:55:53
In reply to Re: CRF Antagonists, posted by jrbecker on May 9, 2003, at 11:10:39
That's very disappointing to hear what Neurocrine and GSK spokesmen said just a year after describing themselves as committed to being world leaders in CRF research and drug development. It makes one wonder how decisive financial considerations must be in all these undertakings. My personal bias is that the tremendous financial investment in SSRI-type drugs may influence these decisions, and act to slow the development of novel classes of AD's.
However, enough is known about the promise and safety of CRF receptor antagonists that I feel confident that research and development will go on somewhere- perhaps not in the US, though. I thought jrbecker had a good suggestion abut other sources to check.
Any progress on the TMS front?
Pfinstegg
poster:Pfinstegg
thread:225118
URL: http://www.dr-bob.org/babble/20030505/msgs/225394.html